Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Capital Expenditures (2016 - 2025)

Perspective Therapeutics' Capital Expenditures history spans 16 years, with the latest figure at $51000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 99.91% to $51000.0 in Q4 2025 year-over-year; TTM through Mar 2026 was $126000.0, a 99.77% decrease, with the full-year FY2025 number at $135000.0, down 99.75% from a year prior.
  • Capital Expenditures hit $51000.0 in Q4 2025 for Perspective Therapeutics, up from $39000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for CATX hit a ceiling of $54.4 million in Q4 2024 and a floor of -$10.1 million in Q3 2024.
  • Historically, Capital Expenditures has averaged $3.1 million across 5 years, with a median of $71500.0 in 2021.
  • The widest YoY moves for Capital Expenditures: up 61012.36% in 2024, down 1142.8% in 2024.
  • Tracing CATX's Capital Expenditures over 5 years: stood at -$86000.0 in 2021, then surged by 275.58% to $151000.0 in 2022, then crashed by 41.06% to $89000.0 in 2023, then surged by 61012.36% to $54.4 million in 2024, then crashed by 99.91% to $51000.0 in 2025.
  • Business Quant data shows Capital Expenditures for CATX at $51000.0 in Q4 2025, $39000.0 in Q3 2025, and $36000.0 in Q2 2025.